Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates

Virology

Volumn 356, Issue 1-2, 2006, Pages 95-105

  Coetzer, Mia ^a   Cilliers, Tonie ^a   Ping, Li Hua ^b   Swanstrom, Ronald ^b   Morris, Lynn ^a  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

CXCR4 usage; HIV 1 subtype C; V3 region; V3 HTA

Indexed keywords

ARGININE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

AMINO ACID SUBSTITUTION; ARTICLE; CONSENSUS; CONTROLLED STUDY; GENETIC ANALYSIS; GLYCOSYLATION; HETERODUPLEX ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MOTIF; SEQUENCE ANALYSIS; VIRUS ISOLATION;

AMINO ACID SEQUENCE; HETERODUPLEX ANALYSIS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, CCR5; RECEPTORS, CXCR4; SEQUENCE ANALYSIS, DNA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33750979833     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.07.030     Document Type: Article

References (45)

1. Abebe A., Demissie D., et al. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. Aids 13 11 (1999) 1305-1311
2. Batra M., Tien P.C., et al. HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe. AIDS Res. Hum. Retroviruses 16 10 (2000) 973-979
3. Berger E.A., Doms R.W., et al. A new classification for HIV-1. Nature 391 6664 (1998) 240
4. Bjorndal A., Sonnerborg A., et al. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res. Hum. Retroviruses 15 7 (1999) 647-653
5. Choge I., Cilliers T., et al. Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C infected children with slow and rapid disease progression. AIDS Res. Hum. Retroviruses 22 5 (2006) 458-465
6. Cilliers T., Nhlapo J., et al. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J. Virol. 77 7 (2003) 4449-4456
7. Cilliers T., Patience T., et al. Sensitivity of HIV type 1 subtype C isolates to the entry inhibitor T-20. AIDS Res. Hum. Retroviruses 20 5 (2004) 477-482
8. Connor R.I., Sheridan K.E., et al. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185 4 (1997) 621-628
9. Cormier E.G., and Dragic T. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J. Virol. 76 17 (2002) 8953-8957
10. De Jong J.J., De Ronde A., et al. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66 11 (1992) 6777-6780
11. Deng H., Liu R., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381 6584 (1996) 661-666
12. Dragic T., Litwin V., et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381 6584 (1996) 667-673
13. Feng Y., Broder C.C., et al. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor [see comments]. Science 272 5263 (1996) 872-877
14. Fouchier R.A., Groenink M., et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66 5 (1992) 3183-3187
15. Fouchier R.A., Brouwer M., et al. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J. Clin. Microbiol. 33 4 (1995) 906-911
16. Hartley O., Klasse P.J., et al. V3: HIV's switch-hitter. AIDS Res. Hum. Retroviruses 21 2 (2005) 171-189
17. Hoffman N.G., Seillier-Moiseiwitsch F., et al. Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J. Virol. 76 8 (2002) 3852-3864
18. Hu Q., Trent J.O., et al. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization. J. Mol. Biol. 302 2 (2000) 359-375
19. Huang C.C., Tang M., et al. Structure of a V3-containing HIV-1 gp120 core. Science 310 5750 (2005) 1025-1028
20. Jensen M.A., Coetzer M., et al. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope v3 sequences. J. Virol. 80 10 (2006) 4698-4704
21. Johnston E.R., Zijenah L.S., et al. High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J. Virol. 77 13 (2003) 7682-7688
22. Korber B.T., Kunstman K.J., et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68 11 (1994) 7467-7481
23. Kuiken C.L., de Jong J.J., et al. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J. Virol. 66 9 (1992) 5704
24. McNearney T., Hornickova Z., et al. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc. Natl. Acad. Sci. U.S.A. 89 21 (1992) 10247-10251
25. Michael N.L., Chang G., et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat. Med. 3 3 (1997) 338-340
26. Milich L., Margolin B.H., et al. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein. Virology 239 1 (1997) 108-118
27. Morris L., Cilliers T., et al. CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res. Hum. Retroviruses 17 8 (2001) 697-701
28. Nabatov A.A., Pollakis G., et al. Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies. J. Virol. 78 1 (2004) 524-530
29. Nelson J.A., Fiscus S.A., et al. Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay. J. Virol. 71 11 (1997) 8750-8758
30. Nelson J.A., Baribaud F., et al. Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection. J. Virol. 74 18 (2000) 8494-8501
31. Ogert R.A., Lee M.K., et al. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J. Virol. 75 13 (2001) 5998-6006
32. Pastore C., Ramos A., et al. Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching. J. Virol. 78 14 (2004) 7565-7574
33. Pastore C., Nedellec R., et al. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J. Virol. 80 2 (2006) 750-758
34. Ping L.H., Nelson J.A., et al. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J. Virol. 73 8 (1999) 6271-6281
35. Pollakis G., Kang S., et al. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J. Biol. Chem. 276 16 (2001) 13433-13441
36. Pollakis G., Abebe A., et al. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals. J. Virol. 78 6 (2004) 2841-2852
37. Polzer S., Dittmar M.T., et al. The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology 304 1 (2002) 70-80
38. Resch W., Hoffman N., et al. Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology 288 1 (2001) 51-62
39. Richman D.D., and Bozzette S.A. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169 5 (1994) 968-974
40. Scarlatti G., Tresoldi E., et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3 11 (1997) 1259-1265
41. Shimizu N., Haraguchi Y., et al. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein. Virology 259 2 (1999) 324-333
42. Shioda T., Levy J.A., et al. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 89 20 (1992) 9434-9438
43. Suphaphiphat P., Thitithanyanont A., et al. Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization. J. Virol. 77 6 (2003) 3832-3837
44. Watabe T., Kishino H., et al. Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host. Genetics 172 3 (2006) 1385-1396
45. Williamson C., Morris L., et al. Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res. Hum. Retroviruses 19 2 (2003) 133-144